Posts in category Healthcare


Joseph Edelman’s Take on 3 Small Cap Biotech Stocks: AcelRx Pharmaceuticals Inc (ACRX), Synergy Pharmaceuticals Inc (SGYP), Antares Pharma Inc (ATRS)

This market-beating fund manager is slashing ACRX and SGYP, but upping ATRS.

Read more

Smarter Analysts’ Biotech Winners to Watch: Apollo Endosurgery Inc (APEN), Avadel Pharmaceuticals plc (AVDL), Beigene Ltd (ADR) (BGNE)

These stocks were recommended by Smarter Analyst’s newsletter BioPortfolio, a standout investment resource that allows …

Read more

2 Pharmaceutical Stocks That Can Double in a Year: Global Blood Therapeutics Inc (GBT), TherapeuticsMD Inc (TXMD)

These two pharma stocks all have upside of over 100% say top Wall Street analysts.

Read more

Quant Investing Guru Jim Simons Rolls Out the Red Carpet for Two Drug Makers: Celsion Corporation (CLSN) and NewLink Genetics Corp (NLNK)

Take a gander at bullish Q2 plays in biotech from one of the richest men in the business.

Read more

“Izzy” Englander Gets More Confident on Endocyte, Inc. (ECYT), Ducks Out from Valeant Pharmaceuticals Intl Inc (VRX)

The hedge fund guru’s Q2 moves added ECYT gains to his pocket while saving him greater losses in VRX.

Read more

Sectoral’s Jerome Pfund Is Losing Faith in PTC Therapeutics, Inc. (PTCT), Starting to Pull Away from Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and DexCom, Inc. (DXCM)

Here’s a glimpse into this hedge fund guru’s Q2 moves that reeled back in three biotech players.

Read more

No Love Lost Between Hedge Fund Guru James “Jim” Flynn and Valeant Pharmaceuticals Intl Inc (VRX), Genocea Biosciences Inc (GNCA); MannKind Corporation (MNKD) Is a Different Story

James “Jim” Flynn first walked onto the Deerfield Management team seventeen years ago, since a …

Read more

Marshall Wace Pulled Back Holding in Intercept Pharmaceuticals Inc (ICPT), Optimistic About Valeant Pharmaceuticals Intl Inc (VRX) and Exelixis, Inc. (EXEL)

A first glance at this hedge fund’s strategic Q2 moves in biotech sector.

Read more

Dmitry Balyasny Sees Potential in Array Biopharma Inc (ARRY), Dumps Valeant Pharmaceuticals Intl Inc (VRX) and Himax Technologies, Inc. (ADR) (HIMX)

Has this billion-dollar fund made the right call on ARRY, VRX, and HIMX?

Read more

World’s Smartest Billionaire Jim Simons Pulls the Trigger on Array Biopharma Inc (ARRY) and Valeant Pharmaceuticals Intl Inc (VRX), Exits Synergy Pharmaceuticals Inc (SGYP)

Three key biopharma trades from the highly-successful $78 billion Renaissance fund

Read more